FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898098722> ?p ?o ?g. }

• W2898098722 endingPage "187" @default.
• W2898098722 startingPage "177" @default.
• W2898098722 abstract "Background: Raltegravir became the first integrase inhibitor to gain FDA approval; but with limited evidence documenting long-term risks in real world care, especially for major health outcomes of interest.Objective: Assess raltegravir safety in clinical practice within an integrated health system.Methods: We conducted a cohort study of HIV-infected adults within Kaiser Permanente California from 2005 to 2013. We compared patients initiating raltegravir during the study period with two groups; a historical cohort (started new antiretroviral regimen [ART] 2005–2007) and a concurrent cohort that did not initiate raltegravir (2007–2013). We used multivariate Cox proportional hazard regression to obtain hazard ratios (HR) for pre-specified incident health outcomes, employing propensity scores to adjust for potential confounding.Results: The population included 8,219 HIV-infected adults (raltegravir cohort N = 1,757; 4,798 patient-years), with greater years known HIV-infected among raltegravir patients. The raltegravir cohort had increased HR for AIDS-defining (HR 2.69 [1.53–4.71]; HR 1.85 [1.21–2.82]) and non-AIDS-defining malignancies (HR 2.26 [1.29–3.94]; HR 1.88 [1.26–2.78]) relative to both comparison cohorts. Compared to the historical cohort we found no significant difference in all-cause mortality; the raltegravir cohort experienced increased HR for all-cause mortality compared to concurrent (HR 1.53 [1.02–2.31]). Raltegravir appeared protective of lipodystrophy when compared to the historical cohort but associated with increased incidence compared to concurrent. There were no significant differences in the incidence of hepatic, skin, or cardiovascular events.Conclusions: The potentially elevated risk for malignancy and mortality with raltegravir and residual confounding merits further investigation. We demonstrate the value of observational cohorts for monitoring post-licensure medication safety." @default.
• W2898098722 created "2018-11-02" @default.
• W2898098722 creator A5005703135 @default.
• W2898098722 creator A5024734562 @default.
• W2898098722 creator A5034360127 @default.
• W2898098722 creator A5039785479 @default.
• W2898098722 creator A5052785465 @default.
• W2898098722 creator A5056868120 @default.
• W2898098722 creator A5068433822 @default.
• W2898098722 creator A5088188519 @default.
• W2898098722 creator A5090971178 @default.
• W2898098722 date "2018-09-03" @default.
• W2898098722 modified "2023-09-27" @default.
• W2898098722 title "Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system" @default.
• W2898098722 cites W1974671307 @default.
• W2898098722 cites W1979402383 @default.
• W2898098722 cites W1994299496 @default.
• W2898098722 cites W1996564823 @default.
• W2898098722 cites W2005218441 @default.
• W2898098722 cites W2016418114 @default.
• W2898098722 cites W2020389183 @default.
• W2898098722 cites W2021606784 @default.
• W2898098722 cites W2022650067 @default.
• W2898098722 cites W2030038632 @default.
• W2898098722 cites W2046101024 @default.
• W2898098722 cites W2049894560 @default.
• W2898098722 cites W2059209195 @default.
• W2898098722 cites W2062648271 @default.
• W2898098722 cites W2068095506 @default.
• W2898098722 cites W2072799291 @default.
• W2898098722 cites W2080861496 @default.
• W2898098722 cites W2109360985 @default.
• W2898098722 cites W2109494999 @default.
• W2898098722 cites W2116146956 @default.
• W2898098722 cites W2126049444 @default.
• W2898098722 cites W2127630510 @default.
• W2898098722 cites W2135417699 @default.
• W2898098722 cites W2148750104 @default.
• W2898098722 cites W2152200519 @default.
• W2898098722 cites W2161780532 @default.
• W2898098722 cites W2161993838 @default.
• W2898098722 cites W2311215932 @default.
• W2898098722 cites W2334065411 @default.
• W2898098722 cites W2580175227 @default.
• W2898098722 cites W2610047059 @default.
• W2898098722 cites W2612297211 @default.
• W2898098722 cites W2613086869 @default.
• W2898098722 cites W2725361041 @default.
• W2898098722 cites W2735790758 @default.
• W2898098722 cites W2761058079 @default.
• W2898098722 cites W2779343225 @default.
• W2898098722 doi "https://doi.org/10.1080/15284336.2018.1523826" @default.
• W2898098722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30370835" @default.
• W2898098722 hasPublicationYear "2018" @default.
• W2898098722 type Work @default.
• W2898098722 sameAs 2898098722 @default.
• W2898098722 citedByCount "8" @default.
• W2898098722 countsByYear W28980987222019 @default.
• W2898098722 countsByYear W28980987222020 @default.
• W2898098722 countsByYear W28980987222021 @default.
• W2898098722 countsByYear W28980987222022 @default.
• W2898098722 countsByYear W28980987222023 @default.
• W2898098722 crossrefType "journal-article" @default.
• W2898098722 hasAuthorship W2898098722A5005703135 @default.
• W2898098722 hasAuthorship W2898098722A5024734562 @default.
• W2898098722 hasAuthorship W2898098722A5034360127 @default.
• W2898098722 hasAuthorship W2898098722A5039785479 @default.
• W2898098722 hasAuthorship W2898098722A5052785465 @default.
• W2898098722 hasAuthorship W2898098722A5056868120 @default.
• W2898098722 hasAuthorship W2898098722A5068433822 @default.
• W2898098722 hasAuthorship W2898098722A5088188519 @default.
• W2898098722 hasAuthorship W2898098722A5090971178 @default.
• W2898098722 hasConcept C120665830 @default.
• W2898098722 hasConcept C121332964 @default.
• W2898098722 hasConcept C126322002 @default.
• W2898098722 hasConcept C142462285 @default.
• W2898098722 hasConcept C201903717 @default.
• W2898098722 hasConcept C207103383 @default.
• W2898098722 hasConcept C2780404665 @default.
• W2898098722 hasConcept C2908647359 @default.
• W2898098722 hasConcept C2993143319 @default.
• W2898098722 hasConcept C3013748606 @default.
• W2898098722 hasConcept C44249647 @default.
• W2898098722 hasConcept C50382708 @default.
• W2898098722 hasConcept C512399662 @default.
• W2898098722 hasConcept C61511704 @default.
• W2898098722 hasConcept C71924100 @default.
• W2898098722 hasConcept C72563966 @default.
• W2898098722 hasConcept C99454951 @default.
• W2898098722 hasConceptScore W2898098722C120665830 @default.
• W2898098722 hasConceptScore W2898098722C121332964 @default.
• W2898098722 hasConceptScore W2898098722C126322002 @default.
• W2898098722 hasConceptScore W2898098722C142462285 @default.
• W2898098722 hasConceptScore W2898098722C201903717 @default.
• W2898098722 hasConceptScore W2898098722C207103383 @default.
• W2898098722 hasConceptScore W2898098722C2780404665 @default.
• W2898098722 hasConceptScore W2898098722C2908647359 @default.
• W2898098722 hasConceptScore W2898098722C2993143319 @default.

• next